SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to patients in ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

The treatment, which will be sold under the brand name Exdensur, is an “ultra-long-acting” version of a biologic treatment ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...

If you fall into any sort of 'underlying health conditions' bracket, you're likely extra concerned about the novel coronavirus pandemic. And if you deal with asthma – caused by the inflammation of the ...

Following the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont ® Scientific Limited sponsored an informative webinar by Intermedical ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Asthma is a common, long-term chronic illness that requires ongoing management. A diagnosis of asthma can affect how much the sufferer pays for travel insurance. According to the British Lung ...